Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL). Our current portfolio is focused on the development of gene therapy programs for the treatment of sensory disorders, ranging from ultra-rare diseases to prevalent conditions, from preclinical to registration stage programs, all with the intent to address significant unmet medical need and bring transformative benefits to patients.